FDA Approves First Generic of Restasis for Dry Eye
Summary : A new option for those affected by keratoconjunctivitis sicca. The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis)…
Summary : A new option for those affected by keratoconjunctivitis sicca. The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis)…
Synopsis : A powerful class of antibiotics called carbapenems can circumvent antibiotic resistance thanks to a particular chain of atoms in their…
The prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact…
Summary : In a clinical trial, the median annualized bleeding rates for all bleeds was reduced from a historical median of 5…
Synopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months,…
Synopsis :: -ImmunityBio shared positive results from the clinical trial of its IL-15 superagonist Anktiva (N-803) to treat people living with human…
Synopsis : Autonomous vehicle industry veteran will build on early success to lead operational growth, oversee geographic expansion, and spearhead Embark’s commercialization…
Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…
Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of…
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…